新兴的光热剂与免疫疗法结合用于癌症治疗
Tian Xu1, Xueping Yang1, Xinyu Chen1
1Department of Oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, Sichuan, China.
Discover oncology
|October 21, 2025
概括
免疫光热疗法 (IPTT),结合光热疗法和免疫检查点抑制剂,为癌症治疗提供了一种协同方法. 本综述强调了光热剂的进步及其对增强抗瘤免疫力的临床潜力.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物医学工程 生物医学工程
背景情况:
- 免疫光热疗法 (IPTT) 结合了免疫检查点抑制剂和光热疗法.
- 这一策略增强了瘤特异性免疫力,并使局部热性除成为可能.
研究的目的:
- 对IPTT的光热剂的进展进行审查和批判性分析.
- 检查这些药物与免疫检查点抑制剂的协同应用.
主要方法:
- 专注于创新的光热剂材料.
- 对免疫光热协同作用背后的机制的分析.
- 对抗瘤功效的临床前和临床研究结果的评估.
主要成果:
- 为了增强IPTT,新型光热材料的进展.
- 证明了促进抗瘤免疫力的协同效应.
- 来自临床前和临床研究的疗效证据.
结论:
- 讨论IPTT临床翻译方面的挑战.
- 探索IPTT未来的研究方向.
- 突出IPTT作为一个有前途的多式模式癌症治疗.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines
917
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
917
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


